[LOGO]

[Text on Screen]
What is ORILISSA?
ORILISSA is a prescription medicine used to treat moderate to severe pain associated with endometriosis. It is not known if ORILISSA is safe and effective in children.

Do not take ORILISSA if you:
Are pregnant, have osteoporosis, have severe liver disease, are taking medicines called OATP 1B1 inhibitors that are known or expected to significantly increase the blood levels of elagolix, the active ingredient in ORILISSA (ask your HCP if you are not sure if you are taking one of these medicines), or have had a serious allergic reaction to ORILISSA or any of the ingredients in ORILISSA. See the end of the Medication Guide for a complete list of ingredients in ORILISSA. Ask your HCP if you are not sure.

Please see additional Important Safety Information and the Full Prescribing Information, including Medication Guide, on this website.

[Text on Screen]
Brit & Amy

DISCUSS PUSHING THROUGH MODERATE TO SEVERE ENDOMETRIOSIS PAIN

Individual results may vary.

AMY:
My endometriosis pain was the most horrible pain—

BRIT:
Yeah.

AMY:
—that I’d ever experienced. And I just thought that…that’s…that was the journey that I had to deal with going through my life. So, I’ll just keep it quiet. I’ll bottle it up.

BRIT:
You don’t want to feel like, um, like you’re making excuses. You don’t want other people to think, uh, any less of you, right? You’re still bringing a hundred even though you’re going through so much. I was coming home from a meeting. It was a big, important meeting, and I was hurting the entire time. And I had to actually get out of the car and sit down. I was sitting on a curb. That was my breaking point, and I knew at that moment, I need to do something about this.

[Text on Screen] 
Please see Important Safety Information and the Full Prescribing Information, including the Medication Guide, on this website. 

AMY:
When my gynecologist first told me about ORILISSA, the more she talked the more I felt hope that there was going to be something that could help me. And the more she listened, the more I got excited. And I was so excited to go home and do my research so that we could sit down and have the conversation, um, about the risk and the benefits. I wanted to weigh those out. I felt that this could be the medication for me.

BRIT:
I feel like we really connect on that one because it’s…it’s so true. When my gynecologist told me about ORILISSA I had a list of questions. And he was very helpful, very reassuring…so I started to feel the same way. Like there’s a little bit of hope at the end of the tunnel.

AMY:
I, I’m so hopeful that women will start to feel they’re empowered and feel they can be a self-advocate for their own health and not have to wait like we did. 

BRIT:
I think it’s so important for every woman to know you don’t need to be pushed to your breaking point to finally speak up and say something. Get answers and demand it. Because you deserve it.

[Text on Screen] 
ASK YOUR GYNECOLOGIST IF ORILISSA COULD BE RIGHT FOR YOU.

[ORILISSA logo]

[Text on Screen/Voiceover]
SAFETY CONSIDERATIONS

Do not use ORILISSA if you are pregnant, have osteoporosis or severe liver disease, take medicines called organic anion transporting polypeptide (OATP) 1B1 inhibitors that are known or expected to significantly increase the blood levels of elagolix (the active ingredient in ORILISSA), or have had a serious allergic reaction to ORILISSA or any of the ingredients in ORILISSA. ORILISSA does not prevent pregnancy. It may alter your period, so watch for other signs of pregnancy. Stop taking ORILISSA if you become pregnant. Ask about proper birth control, as some may affect how ORILISSA works. ORILISSA may affect how some birth control works. ORILISSA can cause serious side effects, including bone loss, abnormal liver tests, suicidal thoughts or behaviors, and worsening mood. Talk to your healthcare provider right away if you notice changes such as jaundice, dark amber-colored urine, suicidal thoughts or actions, depression, or worsening mood.

Please see additional Important Safety Information and the Full Prescribing Information, including Medication Guide, on this website.

US-ORIL-210015